New data out for Btk inhibitors Imbruvica, acalabrutinib

Data presented at the American Society of Hematology (ASH) meeting in San Diego showed response rates for Bruton's tyrosine kinase (Btk) inhibitors Imbruvica ibrutinib to

Read the full 259 word article

User Sign In